Boston Scientific Proceeds from (payments for) investments and acquisitions of certain technologies decreased by 182.4% to -$61.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 179.2%, from $77.00M to -$61.00M. Over 3 years (FY 2021 to FY 2025), Proceeds from (payments for) investments and acquisitions of certain technologies shows an upward trend with a -3.1% CAGR.
Reflects the company's commitment to external innovation and strategic partnerships.
Cash flows related to the purchase or sale of investments in technologies, intellectual property, or minority stakes in...
Varies significantly based on the company's R&D and venture investment strategy.
investing_proceeds_from_payments_for_investments_and_acq_727e7d| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$67.00M | -$187.00M | $0.00 | $10.00M | $21.00M | $10.00M | $63.00M | $16.00M | $0.00 | $66.00M | $73.00M | $125.00M | $16.00M | $77.00M | $33.00M | $70.00M | $74.00M | -$61.00M |
| QoQ Change | — | -179.1% | +100.0% | — | +110.0% | -52.4% | +530.0% | -74.6% | -100.0% | — | +10.6% | +71.2% | -87.2% | +381.3% | -57.1% | +112.1% | +5.7% | -182.4% |
| YoY Change | — | — | — | — | +111.2% | +0.0% | — | -23.8% | — | +560.0% | +15.9% | +681.3% | — | +16.7% | -54.8% | -44.0% | +362.5% | -179.2% |